Exercise Intervention After Lung Cancer Surgery

April 10, 2024 updated by: Region Örebro County

Combination of Supervised and Non-supervised Exercise After Lung Cancer Surgery

A combination of supervised and un-supervised exercise in patients after lung cancer surgery is evaluated with regards to aerobic capacity, strength, physical activity and health-related quality of life.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
      • Örebro, Sweden, 70185
        • Recruiting
        • Orebro University Hospital
        • Contact:
        • Principal Investigator:
          • Marcus Jonsson

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Elective lung cancer surgery
  • Ability to perform tests
  • Able to communicate in Swedish
  • Willing to participate in supervised exercise

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment group
Supervised exercise one session per week, un-supervised exercise two sessions per week, for tree months, followed by three months without organized exercise.
Other: Exercise
Aerobic and strength exercise.
Other: Control group
Three months without organized exercise, followed by the same exercise as the Treatment group for three months.
Other: Exercise
Aerobic and strength exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-minute walk test
Time Frame: 30 minutes
Measuring the distance walked in 6 minutes.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EORTC QLQ-C30/LC13
Time Frame: 10 minutes
Scale 0-100, for function scales higher is better, for symptom scales higher means more symptoms.
10 minutes
30 s chair stands test
Time Frame: 5 minutes
Measuring the number of stands from a chair during 30 seconds.
5 minutes
OMPAQ
Time Frame: 2 minutes
Categorical question on physical activity performed during the last month.
2 minutes
Actigraph GT3X
Time Frame: 7 days
Accelerometer providing information about steps and time in different intensities of physical activity
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Region Örebro County

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

September 26, 2023

First Submitted That Met QC Criteria

November 20, 2023

First Posted (Actual)

November 29, 2023

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 10, 2024

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 281273

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation After Lung Cancer Surgery

Clinical Trials on Exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe